This categorization highlights the dynamic transcriptional change of GBM cells’ behavior in response to chemotherapy and subsequent withdrawal of treatment, suggesting that CL-C subclass may represent an intermediate state in the PN-MES axis. The gene discussed is CLC; the disease is glioblastoma.